North America Cancer Vaccines Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector Cancer Vaccines); Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines); Indication (Cervical Cancer, Prostate Cancer, Other Indications); End User (Pediatrics, Adults), and Country and Geography

No. of Pages: 164    |    Report Code: TIPRE00015129    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Cancer Vaccines Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Cancer Vaccines Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Cancer Vaccines Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increase in Prevalence of Cancer Worldwide
5.2 Market Opportunities
  • 5.2.1 Growing Research and Development Activities
5.3 Future Trends
  • 5.3.1 Emerging Markets in Developing Countries
5.4 Impact of Drivers and Restraints

6. North America Cancer Vaccines Market Regional Analysis

6.1 North America Cancer Vaccines Market Overview
6.2 North America Cancer Vaccines Market Revenue 2017-2027 (US$ Million)
6.3 North America Cancer Vaccines Market Forecast Analysis

7. North America Cancer Vaccines Market Analysis – by Technology

7.1 Dendritic Cells Cancer Vaccines
  • 7.1.1 Overview
  • 7.1.2 Dendritic Cells Cancer Vaccines: North America Cancer Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Recombinant Cancer Vaccines
  • 7.2.1 Overview
  • 7.2.2 Recombinant Cancer Vaccines: North America Cancer Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Antigen Cancer Vaccines
  • 7.3.1 Overview
  • 7.3.2 Antigen Cancer Vaccines: North America Cancer Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Whole Cell Cancer Vaccines
  • 7.4.1 Overview
  • 7.4.2 Whole Cell Cancer Vaccines: North America Cancer Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Viral Vector Cancer Vaccines
  • 7.5.1 Overview
  • 7.5.2 Viral Vector Cancer Vaccines: North America Cancer Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Cancer Vaccines Market Analysis – by Type

8.1 Preventive Cancer Vaccines
  • 8.1.1 Overview
  • 8.1.2 Preventive Cancer Vaccines: North America Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Therapeutic Cancer Vaccines
  • 8.2.1 Overview
  • 8.2.2 Therapeutic Cancer Vaccines: North America Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9. North America Cancer Vaccines Market Analysis – by Indication

9.1 Cervical Cancer
  • 9.1.1 Overview
  • 9.1.2 Therapeutic Cancer Vaccines: North America Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Prostate Cancer
  • 9.2.1 Overview
  • 9.2.2 Therapeutic Cancer Vaccines: North America Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Other Indications
  • 9.3.1 Overview
  • 9.3.2 Therapeutic Cancer Vaccines: North America Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

10. North America Cancer Vaccines Market – North America Analysis

10.1 North America
  • 10.1.1 North America Cancer Vaccines Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.1.1.1 North America Cancer Vaccines Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 US: North America Cancer Vaccines Market Breakdown, by Technology
    • 10.1.1.1.2 US: North America Cancer Vaccines Market Breakdown, by Type
    • 10.1.1.1.3 US: North America Cancer Vaccines Market Breakdown, by Indication
  • 10.1.1.2 Canada: North America Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Canada: North America Cancer Vaccines Market Breakdown, by Technology
    • 10.1.1.2.2 Canada: North America Cancer Vaccines Market Breakdown, by Type
    • 10.1.1.2.3 Canada: North America Cancer Vaccines Market Breakdown, by Indication
  • 10.1.1.3 Mexico : North America Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Cancer Vaccines Market Breakdown, by Technology
    • 10.1.1.3.2 Mexico : North America Cancer Vaccines Market Breakdown, by Type
    • 10.1.1.3.3 Mexico : North America Cancer Vaccines Market Breakdown, by Indication

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Cancer Vaccines Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 AstraZeneca
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 GlaxoSmithKline plc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Aduro Biotech Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Pfizer Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Sanofi
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Bristol-Myers Squibb
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Moderna, Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 OncBioMune Pharmaceuticals Inc.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 MaxiVAX
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Nouscom
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

The List of Companies - North America Cancer Vaccines Market

  1. AstraZeneca
  2. GlaxoSmithKline plc.
  3. Aduro Biotech Inc
  4. Pfizer Inc.
  5. Sanofi
  6. Bristol-Myers Squibb
  7. Moderna, Inc.
  8. OncBioMune Pharmaceuticals Inc.
  9. MaxiVAX
  10. Nouscom
north-america-cancer-vaccines-market